Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Essen Biotech
Memorial Sloan Kettering Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Dana-Farber Cancer Institute
University of Arizona
Mayo Clinic
University of Texas Southwestern Medical Center
Shenzhen Geno-Immune Medical Institute
Cancer Research UK
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Cancer Research UK
Sun Yat-sen University
University of Kansas Medical Center
Hoosier Cancer Research Network
Columbia University
Hoosier Cancer Research Network
University College, London
Zhujiang Hospital
University of Oklahoma
University of British Columbia
Swiss Cancer Institute
Ludwig Institute for Cancer Research
University Health Network, Toronto
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Fraser Health
RenJi Hospital
Baylor College of Medicine
Icahn School of Medicine at Mount Sinai
University of Aarhus
Memorial Sloan Kettering Cancer Center
Cardiff University
Sun Yat-sen University
Memorial Sloan Kettering Cancer Center
Institut du Cancer de Montpellier - Val d'Aurelle
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
North Florida/South Georgia Veterans Health System
Lukas-Krankenhaus GmbH
Uppsala University
Campania Younger Oncologists Association
University Of Perugia